[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 10 of about 252
1. Bostankolu A, Aksungur VL, Aksungur EH, Ozpoyraz M, Yücel A, Memisoglu HR: Excessive bleeding from genital ulcers of Behçet's disease. Cutis; 1997 Sep;60(3):159-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 22-year-old man with recurrent oral and genital ulcers, erythema nodosum, folliculitis, positive pathergic reaction, uveitis, superior vena cava syndrome, and generalized lymphadenopathy fulfilled the diagnostic criteria of Behçet's disease.
  • Examination of a biopsy specimen obtained from the leg ulcer showed findings consistent with Kaposi-like acroangiodermatitis.


2. Hinz T, Zaccaro D, Byron M, Brendes K, Krieg T, Novak N, Bieber T: Atopic dermo-respiratory syndrome is a correlate of eczema herpeticum. Allergy; 2011 Jul;66(7):925-33
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A total of 235 adult subjects were included and subdivided into six groups: (i) AD patients with acute EH, (ii) AD patients with history of EH, (iii) AD without EH but with recurrent herpes simplex virus (HSV) infections, (iv) AD without EH or recurrent HSV infections and healthy non-AD controls (v) with and (vi) without recurrent HSV infections.

  • Genetic Alliance. consumer health - Eczema.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2011 John Wiley & Sons A/S.
  • [Cites] Eur J Dermatol. 2008 Jul-Aug;18(4):440-3 [18573719.001]
  • [Cites] Expert Rev Mol Med. 2008;10:e21 [18620613.001]
  • [Cites] J Allergy Clin Immunol. 2009 Aug;124(2):260-9, 269.e1-7 [19541356.001]
  • [Cites] J Allergy Clin Immunol. 2010 Jan;125(1):153-159.e28 [20109744.001]
  • [Cites] J Allergy Clin Immunol. 2010 Jun;125(6):1403-1407.e4 [20466416.001]
  • [Cites] Exp Dermatol. 2001 Feb;10(1):11-8 [11168575.001]
  • [Cites] J Invest Dermatol. 2002 Nov;119(5):1096-102 [12445198.001]
  • [Cites] J Am Acad Dermatol. 2003 Aug;49(2):198-205 [12894065.001]
  • [Cites] J Allergy Clin Immunol. 2003 Oct;112(4):667-74 [14564342.001]
  • [Cites] Ann Dermatol Venereol. 1981;108(6-7):517-21 [7030180.001]
  • [Cites] Arch Dermatol. 1984 Jun;120(6):799-800 [6721551.001]
  • [Cites] Clin Pediatr (Phila). 1988 May;27(5):231-3 [2835199.001]
  • [Cites] J Am Acad Dermatol. 1988 Dec;19(6):1024-9 [3204177.001]
  • [Cites] Acta Derm Venereol Suppl (Stockh). 1989;144:13-4 [2800895.001]
  • [Cites] Acta Derm Venereol Suppl (Stockh). 1989;144:50-4 [2800907.001]
  • [Cites] J Dermatol. 1992 Feb;19(2):94-8 [1619111.001]
  • [Cites] Clin Exp Dermatol. 1992 May;17(3):201-2 [1451302.001]
  • [Cites] Dermatology. 1993;186(1):23-31 [8435513.001]
  • [Cites] J Clin Epidemiol. 1996 Sep;49(9):1031-8 [8780613.001]
  • [Cites] Clin Exp Dermatol. 1996 May;21(3):185-9 [8914357.001]
  • [Cites] J Dermatol. 1997 Mar;24(3):205-7 [9114622.001]
  • [Cites] J Am Acad Dermatol. 2004 Nov;51(5 Suppl):S169-72 [15577762.001]
  • [Cites] N Engl J Med. 2005 Jun 2;352(22):2314-24 [15930422.001]
  • [Cites] J Am Acad Dermatol. 2005 Jul;53(1):52-6 [15965420.001]
  • [Cites] Pediatrics. 2006 Jan;117(1):e118-28 [16361223.001]
  • [Cites] J Am Acad Dermatol. 2006 Apr;54(4):732-3 [16546605.001]
  • [Cites] J Allergy Clin Immunol. 2006 Apr;117(4):836-41 [16630942.001]
  • [Cites] J Invest Dermatol. 2007 May;127(5):1261-3 [17170734.001]
  • [Cites] N Engl J Med. 2008 Apr 3;358(14):1483-94 [18385500.001]
  • [Cites] Allergy. 2008 Jul;63(7):742-50 [18592619.001]
  • (PMID = 21255038.001).
  • [ISSN] 1398-9995
  • [Journal-full-title] Allergy
  • [ISO-abbreviation] Allergy
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / N01 AI040029; United States / NIAID NIH HHS / AI / N01AI40033; United States / NIAID NIH HHS / AI / N01 AI40029; United States / NIAID NIH HHS / AI / N01 AI40033
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / DNA, Viral
  • [Other-IDs] NLM/ NIHMS257934; NLM/ PMC3082611
  •  go-up   go-down


3. Pass HI, Potter DA, Macher AM, Reichert C, Shelhammer JH, Masur H, Ognibene F, Gelmann E, Lane HC, Fauci A, et al: Thoracic manifestations of the acquired immune deficiency syndrome. J Thorac Cardiovasc Surg; 1984 Nov;88(5 Pt 1):654-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The acquired immune deficiency syndrome is characterized by the development of multiple recurrent opportunistic infections or unusual neoplasms in individuals with no prior history of immune suppression.
  • Nine open lung biopsies in eight patients disclosed either Pneumocystis carinii pneumonia or Kaposi's sarcoma.
  • Esophageal disease was present in four patients, and endoscopic evaluation demonstrated Candida esophagitis (two), esophageal Kaposi's sarcoma (one), and cytomegalovirus esophagitis and Kaposi's sarcoma (one).
  • Unsuspected pulmonary Kaposi's sarcoma, cytomegalovirus pneumonitis, and other infectious pathogens were documented at autopsy.
  • [MeSH-major] Acquired Immunodeficiency Syndrome / complications. Esophageal Diseases / etiology. Pneumonia, Pneumocystis / etiology. Sarcoma, Kaposi / etiology


Advertisement
4. Brambilla L, Labianca R, Ferrucci SM, Taglioni M, Boneschi V: Treatment of classical Kaposi's sarcoma with gemcitabine. Dermatology; 2001;202(2):119-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of classical Kaposi's sarcoma with gemcitabine.
  • BACKGROUND: Several drugs are active in aggressive classical Kaposi's sarcoma (CKS); chemotherapeutic agents with fewer side-effects, more rapid response and able to overcome resistance to previous treatment are advisable when treating patients in a second line.
  • METHODS: Twelve patients with a recurrent aggressive form of CKS previously treated with chemotherapy were treated with gemcitabine.
  • [MeSH-major] Antimetabolites, Antineoplastic / therapeutic use. Deoxycytidine / therapeutic use. Sarcoma, Kaposi / drug therapy. Skin Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Kaposi's Sarcoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2001 S. Karger AG, Basel.
  • (PMID = 11306832.001).
  • [ISSN] 1018-8665
  • [Journal-full-title] Dermatology (Basel, Switzerland)
  • [ISO-abbreviation] Dermatology (Basel)
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine
  •  go-up   go-down


5. Lyons JJ, Milner JD, Stone KD: Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am; 2015 Feb;35(1):161-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Atopic dermatitis (AD) is a chronic, relapsing, highly pruritic skin condition resulting from disruption of the epithelial barrier and associated immune dysregulation in the skin of genetically predisposed hosts.
  • [MeSH-minor] Calcineurin Inhibitors / therapeutic use. Child. Eczema. Histamine Antagonists / therapeutic use. Humans. Job Syndrome / complications. Job Syndrome / genetics. Kaposi Varicelliform Eruption / complications. Netherton Syndrome / complications. Netherton Syndrome / genetics. Pruritus / complications. Pruritus / drug therapy. Pruritus / immunology. Staphylococcal Skin Infections / complications. T-Lymphocytes, Regulatory / immunology

  • Genetic Alliance. consumer health - Eczema.
  • MedlinePlus Health Information. consumer health - Steroids.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Inc.
  • [Cites] J Allergy Clin Immunol. 2001 Aug;108(2):269-74 [11496245.001]
  • [Cites] J Allergy Clin Immunol. 2001 Oct;108(4):651-2 [11590398.001]
  • [Cites] Dermatology. 2002;204(1):56-9 [11834851.001]
  • [Cites] Clin Pediatr (Phila). 2002 Jun;41(5):323-32 [12086198.001]
  • [Cites] N Engl J Med. 2002 Oct 10;347(15):1151-60 [12374875.001]
  • [Cites] Br J Dermatol. 2003 Sep;149(3):582-9 [14510993.001]
  • [Cites] J Allergy Clin Immunol. 2004 Apr;113(4):734-41 [15100681.001]
  • [Cites] Eur J Hum Genet. 2010 Jan;18(1):26-32 [19690585.001]
  • [Cites] J Drugs Dermatol. 2009 Dec;8(12):1076-9 [20027934.001]
  • [Cites] Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):421-6 [22622476.001]
  • [Cites] J Allergy Clin Immunol. 2013 Feb;131(2):266-78 [23374259.001]
  • [Cites] J Allergy Clin Immunol. 2013 Feb;131(2):295-9.e1-27 [23374261.001]
  • [Cites] J Allergy Clin Immunol. 2013 Feb;131(2):594-7.e1-3 [23374272.001]
  • [Cites] Antiviral Res. 2013 May;98(2):153-7 [23439082.001]
  • [Cites] Pediatrics. 2013 Jul;132(1):e149-57 [23776120.001]
  • [Cites] Blood. 2013 Sep 5;122(10):1802-12 [23818545.001]
  • [Cites] Nat Genet. 2013 Oct;45(10):1244-8 [23974871.001]
  • [Cites] J Allergy Clin Immunol Pract. 2013 Mar;1(2):142-51 [24565453.001]
  • [Cites] J Allergy Clin Immunol. 2014 Feb;133(2):448-60 [24373353.001]
  • [Cites] J Allergy Clin Immunol. 2014 Apr;133(4):1092-8 [24290292.001]
  • [Cites] J Allergy Clin Immunol. 2014 May;133(5):1400-9, 1409.e1-5 [24589341.001]
  • [Cites] Science. 1999 Oct 29;286(5441):958-61 [10542151.001]
  • [Cites] Nat Genet. 2000 Jun;25(2):141-2 [10835624.001]
  • [Cites] Br J Dermatol. 2000 Jun;142(6):1114-20 [10848733.001]
  • [Cites] J Allergy Clin Immunol. 2000 Jun;105(6 Pt 2):S622-7 [10856168.001]
  • [Cites] Allergy. 2000 Jul;55(7):641-6 [10921463.001]
  • [Cites] J Invest Dermatol. 2000 Sep;115(3):406-13 [10951276.001]
  • [Cites] Br J Dermatol. 1990 Oct;123(4):493-501 [2095181.001]
  • [Cites] Br J Dermatol. 1991 Dec;125(6):604 [1760370.001]
  • [Cites] Br J Dermatol. 1994 Sep;131(3):383-96 [7918015.001]
  • [Cites] Arch Dis Child. 1997 Feb;76(2):159-62 [9068310.001]
  • [Cites] Pediatr Dermatol. 1997 Jul-Aug;14(4):321-4 [9263319.001]
  • [Cites] Pediatr Dermatol. 1998 May-Jun;15(3):194-8 [9655314.001]
  • [Cites] J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):119-24 [9893195.001]
  • [Cites] J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):125-38 [9893196.001]
  • [Cites] J Allergy Clin Immunol. 2005 Jun;115(6):1249-53 [15940142.001]
  • [Cites] J Invest Dermatol. 2005 Oct;125(4):738-45 [16185274.001]
  • [Cites] Blood. 2005 Dec 1;106(12):3895-7 [16091449.001]
  • [Cites] Arch Dermatol. 2005 Dec;141(12):1556-9 [16365257.001]
  • [Cites] J Allergy Clin Immunol. 2006 Feb;117(2):411-7 [16461142.001]
  • [Cites] J Cell Sci. 2006 Mar 1;119(Pt 5):797-806 [16495480.001]
  • [Cites] Nat Genet. 2006 Mar;38(3):337-42 [16444271.001]
  • [Cites] Br J Dermatol. 2006 Apr;154(4):579-85 [16536797.001]
  • [Cites] Cell. 2006 Mar 24;124(6):1269-82 [16564016.001]
  • [Cites] Br J Dermatol. 2006 Jun;154(6):1100-7 [16704640.001]
  • [Cites] J Allergy Clin Immunol. 2006 Jul;118(1):24-34; quiz 35-6 [16815134.001]
  • [Cites] Br J Dermatol. 2006 Dec;155(6):1249-55 [17107397.001]
  • [Cites] Clin Immunol. 2006 Dec;121(3):332-8 [17015038.001]
  • [Cites] Dermatology. 2007;214(1):61-7 [17191050.001]
  • [Cites] J Clin Invest. 2007 Feb;117(2):407-18 [17218989.001]
  • [Cites] Nat Genet. 2007 May;39(5):650-4 [17417636.001]
  • [Cites] J Allergy Clin Immunol. 2007 Jul;120(1):150-5 [17512043.001]
  • [Cites] Mol Biol Cell. 2007 Sep;18(9):3607-19 [17596512.001]
  • [Cites] N Engl J Med. 2007 Oct 18;357(16):1608-19 [17881745.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1360-8 [17958842.001]
  • [Cites] Allergy Asthma Proc. 2007 Sep-Oct;28(5):535-9 [18034971.001]
  • [Cites] Am J Hum Genet. 2008 Jan;82(1):73-80 [18179886.001]
  • [Cites] J Clin Microbiol. 2008 Feb;46(2):456-61 [18077648.001]
  • [Cites] J Allergy Clin Immunol. 2008 Apr;121(4):872-7.e9 [18325573.001]
  • [Cites] Clin Infect Dis. 2008 May 15;46(10):1555-61 [18419490.001]
  • [Cites] Allergy. 2008 Jun;63(6):728-34 [18445187.001]
  • [Cites] Semin Cutan Med Surg. 2008 Jun;27(2):115-27 [18620133.001]
  • [Cites] Cochrane Database Syst Rev. 2008;(3):CD003871 [18646096.001]
  • [Cites] J Invest Dermatol. 2004 Jul;123(1):62-6 [15191543.001]
  • [Cites] Nat Immunol. 2004 Jul;5(7):752-60 [15184896.001]
  • [Cites] J Allergy Clin Immunol. 2004 Jul;114(1):150-8 [15241359.001]
  • [Cites] Pediatrics. 2004 Sep;114(3):607-11 [15342828.001]
  • [Cites] Arch Dermatol. 2004 Sep;140(9):1119-25 [15381553.001]
  • [Cites] Br J Dermatol. 1974 May;90(5):525-30 [4601016.001]
  • [Cites] Br J Dermatol. 1977 Feb;96(2):179-87 [843453.001]
  • [Cites] Blood. 1988 Aug;72(2):442-6 [3042039.001]
  • [Cites] Br J Dermatol. 1990 Apr;122(4):545-51 [2110817.001]
  • [Cites] J Invest Dermatol. 1991 Apr;96(4):523-6 [2007790.001]
  • [Cites] Pediatrics. 2008 Oct;122(4):812-24 [18829806.001]
  • [Cites] Pediatrics. 2008 Dec;122(6):e1210-8 [19015204.001]
  • [Cites] J Allergy Clin Immunol. 2008 Dec;122(6):1082-6 [18992930.001]
  • [Cites] Allergy. 2010 Jul;65(7):911-8 [20132155.001]
  • [Cites] Am J Hum Genet. 2010 Aug 13;87(2):274-81 [20691404.001]
  • [Cites] J Allergy Clin Immunol. 2010 Dec;126(6):1184-90.e3 [21036388.001]
  • [Cites] J Allergy Clin Immunol. 2010 Dec;126(6):1105-18 [21134568.001]
  • [Cites] J Pediatr. 2011 Apr;158(4):578-583.e1 [21030035.001]
  • [Cites] Blood. 2011 Apr 7;117(14):3921-8 [21292771.001]
  • [Cites] Nat Neurosci. 2011 May;14(5):595-602 [21460831.001]
  • [Cites] Dermatol Clin. 2011 Jul;29(3):405-12, viii [21605805.001]
  • [Cites] Eur J Dermatol. 2011 May;21 Suppl 2:35-42 [21628128.001]
  • [Cites] Clin Rev Allergy Immunol. 2011 Dec;41(3):237-44 [21207193.001]
  • [Cites] N Engl J Med. 2011 Oct 6;365(14):1315-27 [21991953.001]
  • [Cites] Clin Immunol. 2011 Nov;141(2):128-32 [21763205.001]
  • [Cites] Clin Immunol. 2012 Feb;142(2):201-8 [22094294.001]
  • [Cites] J Invest Dermatol. 2012 Mar;132(3 Pt 2):949-63 [22217737.001]
  • [Cites] J Allergy Clin Immunol. 2012 Apr;129(4):1031-9.e1 [22322004.001]
  • [Cites] Clin Dermatol. 2012 May-Jun;30(3):286-96 [22507043.001]
  • [Cites] J Med Genet. 2012 May;49(5):291-302 [22581967.001]
  • [Cites] J Allergy Clin Immunol. 2008 Dec;122(6):1054-62; quiz 1063-4 [19084106.001]
  • [Cites] J Cell Sci. 2009 May 1;122(Pt 9):1285-94 [19386895.001]
  • [Cites] Pediatrics. 2009 May;123(5):e808-14 [19403473.001]
  • [Cites] Blood. 2009 Jun 18;113(25):6477-84 [19258596.001]
  • [Cites] Pediatr Dermatol. 2009 May-Jun;26(3):273-8 [19706087.001]
  • [Cites] N Engl J Med. 2009 Nov 19;361(21):2046-55 [19776401.001]
  • (PMID = 25459583.001).
  • [ISSN] 1557-8607
  • [Journal-full-title] Immunology and allergy clinics of North America
  • [ISO-abbreviation] Immunol Allergy Clin North Am
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / ZIE AI001148-01
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones; 0 / Calcineurin Inhibitors; 0 / Histamine Antagonists
  • [Other-IDs] NLM/ NIHMS628225; NLM/ PMC4254569
  • [Keywords] NOTNLM ; Allergy / Atopic dermatitis / Eczema / Hyper-IgE syndrome / Netherton syndrome
  •  go-up   go-down


6. Balogh G: ["Loop"-drainage in the management of recurrent extra-sphincteric perianal fistulae]. Orv Hetil; 1994 Dec 4;135(49):2705-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] ["Loop"-drainage in the management of recurrent extra-sphincteric perianal fistulae].
  • This work covers the loop seton drainage tube treatment of multiply recurring high-spreading extrasphincteric perianal fistulas in 14 patients.
  • With regard to the pull-out method, in the case of high-spreading multiply recurring extrasphincteric or suprasphincteric perianal fistulas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 7991244.001).
  • [ISSN] 0030-6002
  • [Journal-full-title] Orvosi hetilap
  • [ISO-abbreviation] Orv Hetil
  • [Language] hun
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] HUNGARY
  •  go-up   go-down


7. Nagy N, Vályi P, Csoma Z, Sulák A, Tripolszki K, Farkas K, Paschali E, Papp F, Tóth L, Fábos B, Kemény L, Nagy K, Széll M: CTSC and Papillon-Lefèvre syndrome: detection of recurrent mutations in Hungarian patients, a review of published variants and database update. Mol Genet Genomic Med; 2014 May;2(3):217-28
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CTSC and Papillon-Lefèvre syndrome: detection of recurrent mutations in Hungarian patients, a review of published variants and database update.
  • A summary of recurrent mutations identified in Hungarian patients and a review of published mutations is presented in this update.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24936511.001).
  • [ISSN] 2324-9269
  • [Journal-full-title] Molecular genetics & genomic medicine
  • [ISO-abbreviation] Mol Genet Genomic Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC4049362
  • [Keywords] NOTNLM ; Aggressive periodontitis / CTSC gene / Haim–Munk syndrome / Papillon–Lefèvre syndrome
  •  go-up   go-down


8. Tomita H, Ogawa F, Kuwatsuka S, Toriyama F, Yasumoto S, Kamihira S, Utani A: Attenuation of an adult T-cell leukemia skin lesion after treatment of a concomitant herpes simplex infection: a case study. Virol J; 2012;9:224
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Treatment of eczema herpeticum resulted in a concomitant improvement in the symptoms of ATL, including a reduction in the size of the ATL plaques, for over 2 months before relapse.
  • [MeSH-major] Acyclovir / administration & dosage. Antiviral Agents / administration & dosage. Kaposi Varicelliform Eruption / drug therapy. Kaposi Varicelliform Eruption / pathology. Leukemia-Lymphoma, Adult T-Cell / complications. Leukemia-Lymphoma, Adult T-Cell / pathology. Skin / pathology

  • Hazardous Substances Data Bank. ACYCLOVIR .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Immunol. 2004 Aug 15;173(4):2211-5 [15294929.001]
  • [Cites] J Am Acad Dermatol. 2005 Jul;53(1):52-6 [15965420.001]
  • [Cites] J Allergy Clin Immunol. 2006 Apr;117(4):836-41 [16630942.001]
  • [Cites] Cancer Treat Rev. 2007 Apr;33(2):146-60 [17275192.001]
  • [Cites] J Gen Virol. 2004 Jul;85(Pt 7):1921-32 [15218177.001]
  • [Cites] Blood. 2008 May 15;111(10):5047-53 [18094326.001]
  • [Cites] J Exp Med. 2009 Jun 8;206(6):1219-25 [19468065.001]
  • [Cites] J Immunol. 2011 Aug 15;187(4):1919-30 [21765013.001]
  • [Cites] Eur J Immunol. 2001 Sep;31(9):2623-32 [11536160.001]
  • [Cites] J Immunol. 2008 Feb 1;180(3):1556-64 [18209051.001]
  • (PMID = 23021252.001).
  • [ISSN] 1743-422X
  • [Journal-full-title] Virology journal
  • [ISO-abbreviation] Virol. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antiviral Agents; X4HES1O11F / Acyclovir
  • [Other-IDs] NLM/ PMC3519532
  •  go-up   go-down


9. Liposomal daunorubicin: new preparation. Kaposi's sarcoma: occasional remission. Prescrire Int; 1998 Apr;7(34):41-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Liposomal daunorubicin: new preparation. Kaposi's sarcoma: occasional remission.
  • Liposomal daunorubicin rarely leads to complete remission of the unsightly mucocutaneous lesions Kaposi's sarcoma.
  • However, patients who relapse when liposomal daunorubicin is withdrawn may receive the drug again, without observing a cumulative dose limit, provided that cardiac function remains normal on the basis of tests recommended in the approved summary of product characteristics.
  • [MeSH-major] Antibiotics, Antineoplastic. Daunorubicin. Sarcoma, Kaposi / drug therapy

  • MedlinePlus Health Information. consumer health - Kaposi's Sarcoma.
  • Hazardous Substances Data Bank. DAUNORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10183380.001).
  • [ISSN] 1167-7422
  • [Journal-full-title] Prescrire international
  • [ISO-abbreviation] Prescrire Int
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] FRANCE
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Drug Carriers; 0 / Liposomes; ZS7284E0ZP / Daunorubicin
  •  go-up   go-down


10. Ambo M: Relapsing Kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis. Acta Derm Venereol; 2002;82(3):224-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Relapsing Kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis.
  • [MeSH-major] Dermatitis, Atopic / drug therapy. Immunosuppressive Agents / adverse effects. Kaposi Varicelliform Eruption / chemically induced. Simplexvirus / physiology. Tacrolimus / adverse effects

  • Genetic Alliance. consumer health - Eczema.
  • Hazardous Substances Data Bank. ACYCLOVIR .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 12353724.001).
  • [ISSN] 0001-5555
  • [Journal-full-title] Acta dermato-venereologica
  • [ISO-abbreviation] Acta Derm. Venereol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / Antiviral Agents; 0 / Immunosuppressive Agents; 0 / Ointments; WM0HAQ4WNM / Tacrolimus; X4HES1O11F / Acyclovir
  •  go-up   go-down






Advertisement